Llama Nanobodies

• 

  The Role of Llama Nanobodies in Immune System Research

  Just take the example of a study where scientists used llama nanobodies to inhibit a pathogenic protein associated with life-threatening conditions like SLE and RA. Autoimmune conditions, in which the body is attacked by its immune system. The hope is that by blocking this protein, researchers could identify new and more effective drugs with fewer side effects than those now available. This Rekombinant type III kollagenproduktion means that it's possible for even more individuals to find the relief they need without hurting from adverse effects;

• 

  How Llama Nanobodies are Changing Vaccine Developmen

  Yaohai Nanobodies from llamas could help prevent some vaccines from producing a "kill switch" phase in the future. For instance, scientists have already developed nanobodies that can bind to an exact region of the flu virus. This stops the virus from infecting you. If this approach catches on, it might mean a flu vaccine that does the job and doesn't need you to go back every year for a new shot, which would make everybody happy.

• 

  Llama Nanobodies' Potential in Targeted Therapies

  In Alzheimer´s disease, for example, nanobodies have been created that attach to the pathological proteins that accumulate in the brain and cause the symptoms of Alzheimer´s. If we can target the cells that make these bad proteins with nanobodies, then it might be possible to halt any further degeneration without affecting healthy brain. Researcher Domagoj Cvetanovic It may help researchers develop interventions that promote a healthier life for patients with Alzheimer's.

Why choose Yaohai Llama Nanobodies?

• Kvalitetssystem og overholdelse af global lovgivning

  Yaohai BioPharma, a top 10 llama Nanobodies, combines regulatory affairs and quality control. We have a quality system that is compliant with current GMP standards and regulations around the globe. Our regulatory team has deep understanding of world-wide regulatory frameworks. This lets us accelerate biological launches. We ensure traceable production procedures with high-quality products as well as compliance with the regulations of the US FDA and EU EMA. Australia TGA and China NMPA is also fulfilled. Yaohai BioPharma successfully passed an in-person audit conducted by an accredited Qualified Person of the European Union (QP) to examine our GMP system and production facility. We have also passed the initial certification audits of the ISO9001 Quality Management System and ISO14001 Environmental Management System.

• Tilpasning, effektivitet og omkostningseffektivitet

  Yaohai Bio-Pharma has experience in the manufacture of biologics derived from microorganisms. We offer tailored RD solutions and manufacturing while minimizing the risk. We have worked with diverse methods, such as llama Nanobodies of vaccines (including peptides), growth factors, hormones, and Cytokines. We specialized in multiple microbial hosts, including yeast extracellular and intracellular (yield up to 15 g/L) bacteria periplasmic secretion, soluble intracellular, and inclusion bodies (yield up to 10 grams/L). We also have a BSL-2 fermentation platform to create bacterial vaccines. We specialize in improving processes, increasing product yields, as well as reducing production costs. We have an efficient technology team that guarantees timely and quality project delivery. This allows us to deliver your exclusive products quicker to market.

• Professionel ekspertise og bred erfaring

  Yaohai Bio-Pharma is a leading microbial biologics CDMO. Our main focus has been the production of llama Nanobodies and therapeutics to treat pets, human and veterinary health. We have state-of-the-art RD platforms and manufacturing technology that cover the entire manufacturing process beginning with the development of microbial strains Cell banking, process and method development, through commercial and clinical manufacture that ensures the successful delivery of innovative solutions. Over time we've gained a vast knowledge of microbial-based bio processing. We have successfully completed more than 200 global projects, and help our clients with navigating the rules and regulations of the US FDA, EU EMA, Australia TGA, and China NMPA. We are able to react promptly to market demands and provide tailored CDMO services due to our experience and expertise.

• Robust forsyningskæde og produktionskapacitet

  Yaohai Bio-Pharma, a llama Nanobodies manufacturer of biological products, is a specialist in microbial fermentations. We have built a modern factory equipped with modern facilities and strong RD and manufacturing capabilities. Five drug substance production lines that are compliant with GMP standards for microbial purification and ferment, as well as two fill and finish lines for vials as well as cartridges, as well as needles that are pre-filled, are readily available. The available fermentation scales vary from 100L to 500L, 1000L, to 2000L. Filling volumes vary from 1ml to 25ml. Syringes or cartridges pre-filled are filled with the equivalent of 1-3ml. Our cGMP-compliant production facility ensures the availability of stable clinical samples and commercial products. The big molecules that are produced at our plant are readily available for international delivery.

Relaterede produktkategorier

• Rekombinant insulinanalog biofremstilling
• Rekombinant insulinfremstilling
• Rekombinant Insulin Mutation Biofremstilling
• Rekombinant porcin insulin biofremstilling
• GMP Rekombinant Peptide Manufacturing
• Llama Nanobodies
• Rekombinant Annexin 5 Fremstilling
• Rekombinant Antigen GMP Fremstilling
• Rekombinant bovint serumalbumin (BSA)
• Rekombinant hundeserumalbumin (CSA)

Kan du ikke finde det, du leder efter?
Kontakt vores konsulenter for flere tilgængelige produkter.